Yes there are a few of us here that had to live through the LCT saga. PAA is run by much sharper minds imo. They have both scientific, business and financial knowledge. Not to mention a mich simpler product, with a far larger market.
Ps I would love NTCELL to find a way to market - would change many patients lives, but PAA will have multiple products on market before LCT wven gets to Ph III imo
Ann: Confirmation of Preliminary COVID-19 Results, page-243
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $44.81K | 255.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11771 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 210082 | 6 |
View Market Depth
| Last trade - 14.52pm 09/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |